Western Blot results showed that TGF-β1 treatment could effectively upregulate TROY expression and activate PI3K/AKT/TBX3 signaling in HCC cells (Fig. 7I, Supplementary Fig. 8H). The gene discussed is TBX3; the disease is hepatocellular carcinoma.